Safety of a New Synbiotic Starter Formula
Purpose: Breastfeeding is the best way to feed all infants, but not all infants can be (exclusively) breastfed. Cow's milk based infant formula is the second choice infant feeding. Methods: The safety of a new synbiotic infant formula, supplemented with Bifidobacterium lactis and fructo-oligosa...
Gespeichert in:
Veröffentlicht in: | Pediatric gastroenterology, hepatology & nutrition hepatology & nutrition, 2017, Vol.20 (3), p.167-177 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | kor |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 177 |
---|---|
container_issue | 3 |
container_start_page | 167 |
container_title | Pediatric gastroenterology, hepatology & nutrition |
container_volume | 20 |
creator | Vandenplas, Yvan Analitis, Antonis Tziouvara, Chara Kountzoglou, Athina Drakou, Anastasia Tsouvalas, Manos Mavroudi, Antigoni Xinias, Ioannis |
description | Purpose: Breastfeeding is the best way to feed all infants, but not all infants can be (exclusively) breastfed. Cow's milk based infant formula is the second choice infant feeding. Methods: The safety of a new synbiotic infant formula, supplemented with Bifidobacterium lactis and fructo-oligosaccharides, with lactose and a whey/casein 60/40 protein ratio was tested in 280 infants during 3 months. Results: The median age of the infants at inclusion was 0.89 months. Weight evolution was in accordance with the World Health Organization growth charts for exclusive breastfed infants. The evolution of all anthropometric parameters (weight-for-length z score and body mass index-for-age z score) was within the normal range. The incidence of functional constipation (3.2%), daily regurgitation (10.9%), infantile crying and colic (10.5%) were all significantly lower than the reported median prevalence for a similar age according to literature (median value of 7.8% for functional constipation, 26.7% for regurgitation, 17.7% for infantile colic). Conclusion: The new synbiotic infant starter formula was safe, resulted in normal growth and was well tolerated. Functional gastro-intestinal manifestations (functional constipation, regurgitation and colic) were significantly lower than reported in literature. Synbiotics (Bifidobacterium lactis and fructo-oligosaccharides) in cow's milk based infant formula bring the second choice infant feeding, formula, closer to the golden standard, exclusive breastfeeding. |
format | Article |
fullrecord | <record><control><sourceid>kisti</sourceid><recordid>TN_cdi_kisti_ndsl_JAKO201730048508409</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JAKO201730048508409</sourcerecordid><originalsourceid>FETCH-kisti_ndsl_JAKO2017300485084093</originalsourceid><addsrcrecordid>eNpjYuA0MjI20bWwMDFggbHNTMw4GHiLizOTDIwtDMzNjEwMOBk0gxPTUksqFfLTFBIV_FLLFYIr85Iy80sykxWCSxKLSlKLFNzyi3JLcxJ5GFjTEnOKU3mhNDeDqptriLOHbnZmcUlmfF5KcU68l6O3v5GBobmxgYGJhakB0HZLY2LVAQBR5TAZ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Safety of a New Synbiotic Starter Formula</title><source>KoreaMed Synapse</source><source>PubMed Central Open Access</source><source>KoreaMed Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Vandenplas, Yvan ; Analitis, Antonis ; Tziouvara, Chara ; Kountzoglou, Athina ; Drakou, Anastasia ; Tsouvalas, Manos ; Mavroudi, Antigoni ; Xinias, Ioannis</creator><creatorcontrib>Vandenplas, Yvan ; Analitis, Antonis ; Tziouvara, Chara ; Kountzoglou, Athina ; Drakou, Anastasia ; Tsouvalas, Manos ; Mavroudi, Antigoni ; Xinias, Ioannis</creatorcontrib><description>Purpose: Breastfeeding is the best way to feed all infants, but not all infants can be (exclusively) breastfed. Cow's milk based infant formula is the second choice infant feeding. Methods: The safety of a new synbiotic infant formula, supplemented with Bifidobacterium lactis and fructo-oligosaccharides, with lactose and a whey/casein 60/40 protein ratio was tested in 280 infants during 3 months. Results: The median age of the infants at inclusion was 0.89 months. Weight evolution was in accordance with the World Health Organization growth charts for exclusive breastfed infants. The evolution of all anthropometric parameters (weight-for-length z score and body mass index-for-age z score) was within the normal range. The incidence of functional constipation (3.2%), daily regurgitation (10.9%), infantile crying and colic (10.5%) were all significantly lower than the reported median prevalence for a similar age according to literature (median value of 7.8% for functional constipation, 26.7% for regurgitation, 17.7% for infantile colic). Conclusion: The new synbiotic infant starter formula was safe, resulted in normal growth and was well tolerated. Functional gastro-intestinal manifestations (functional constipation, regurgitation and colic) were significantly lower than reported in literature. Synbiotics (Bifidobacterium lactis and fructo-oligosaccharides) in cow's milk based infant formula bring the second choice infant feeding, formula, closer to the golden standard, exclusive breastfeeding.</description><identifier>ISSN: 2234-8646</identifier><identifier>EISSN: 2234-8840</identifier><language>kor</language><ispartof>Pediatric gastroenterology, hepatology & nutrition, 2017, Vol.20 (3), p.167-177</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,4024</link.rule.ids></links><search><creatorcontrib>Vandenplas, Yvan</creatorcontrib><creatorcontrib>Analitis, Antonis</creatorcontrib><creatorcontrib>Tziouvara, Chara</creatorcontrib><creatorcontrib>Kountzoglou, Athina</creatorcontrib><creatorcontrib>Drakou, Anastasia</creatorcontrib><creatorcontrib>Tsouvalas, Manos</creatorcontrib><creatorcontrib>Mavroudi, Antigoni</creatorcontrib><creatorcontrib>Xinias, Ioannis</creatorcontrib><title>Safety of a New Synbiotic Starter Formula</title><title>Pediatric gastroenterology, hepatology & nutrition</title><addtitle>Pediatric gastroenterology, hepatology & nutrition</addtitle><description>Purpose: Breastfeeding is the best way to feed all infants, but not all infants can be (exclusively) breastfed. Cow's milk based infant formula is the second choice infant feeding. Methods: The safety of a new synbiotic infant formula, supplemented with Bifidobacterium lactis and fructo-oligosaccharides, with lactose and a whey/casein 60/40 protein ratio was tested in 280 infants during 3 months. Results: The median age of the infants at inclusion was 0.89 months. Weight evolution was in accordance with the World Health Organization growth charts for exclusive breastfed infants. The evolution of all anthropometric parameters (weight-for-length z score and body mass index-for-age z score) was within the normal range. The incidence of functional constipation (3.2%), daily regurgitation (10.9%), infantile crying and colic (10.5%) were all significantly lower than the reported median prevalence for a similar age according to literature (median value of 7.8% for functional constipation, 26.7% for regurgitation, 17.7% for infantile colic). Conclusion: The new synbiotic infant starter formula was safe, resulted in normal growth and was well tolerated. Functional gastro-intestinal manifestations (functional constipation, regurgitation and colic) were significantly lower than reported in literature. Synbiotics (Bifidobacterium lactis and fructo-oligosaccharides) in cow's milk based infant formula bring the second choice infant feeding, formula, closer to the golden standard, exclusive breastfeeding.</description><issn>2234-8646</issn><issn>2234-8840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>JDI</sourceid><recordid>eNpjYuA0MjI20bWwMDFggbHNTMw4GHiLizOTDIwtDMzNjEwMOBk0gxPTUksqFfLTFBIV_FLLFYIr85Iy80sykxWCSxKLSlKLFNzyi3JLcxJ5GFjTEnOKU3mhNDeDqptriLOHbnZmcUlmfF5KcU68l6O3v5GBobmxgYGJhakB0HZLY2LVAQBR5TAZ</recordid><startdate>2017</startdate><enddate>2017</enddate><creator>Vandenplas, Yvan</creator><creator>Analitis, Antonis</creator><creator>Tziouvara, Chara</creator><creator>Kountzoglou, Athina</creator><creator>Drakou, Anastasia</creator><creator>Tsouvalas, Manos</creator><creator>Mavroudi, Antigoni</creator><creator>Xinias, Ioannis</creator><scope>JDI</scope></search><sort><creationdate>2017</creationdate><title>Safety of a New Synbiotic Starter Formula</title><author>Vandenplas, Yvan ; Analitis, Antonis ; Tziouvara, Chara ; Kountzoglou, Athina ; Drakou, Anastasia ; Tsouvalas, Manos ; Mavroudi, Antigoni ; Xinias, Ioannis</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-kisti_ndsl_JAKO2017300485084093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>kor</language><creationdate>2017</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vandenplas, Yvan</creatorcontrib><creatorcontrib>Analitis, Antonis</creatorcontrib><creatorcontrib>Tziouvara, Chara</creatorcontrib><creatorcontrib>Kountzoglou, Athina</creatorcontrib><creatorcontrib>Drakou, Anastasia</creatorcontrib><creatorcontrib>Tsouvalas, Manos</creatorcontrib><creatorcontrib>Mavroudi, Antigoni</creatorcontrib><creatorcontrib>Xinias, Ioannis</creatorcontrib><collection>KoreaScience</collection><jtitle>Pediatric gastroenterology, hepatology & nutrition</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vandenplas, Yvan</au><au>Analitis, Antonis</au><au>Tziouvara, Chara</au><au>Kountzoglou, Athina</au><au>Drakou, Anastasia</au><au>Tsouvalas, Manos</au><au>Mavroudi, Antigoni</au><au>Xinias, Ioannis</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Safety of a New Synbiotic Starter Formula</atitle><jtitle>Pediatric gastroenterology, hepatology & nutrition</jtitle><addtitle>Pediatric gastroenterology, hepatology & nutrition</addtitle><date>2017</date><risdate>2017</risdate><volume>20</volume><issue>3</issue><spage>167</spage><epage>177</epage><pages>167-177</pages><issn>2234-8646</issn><eissn>2234-8840</eissn><abstract>Purpose: Breastfeeding is the best way to feed all infants, but not all infants can be (exclusively) breastfed. Cow's milk based infant formula is the second choice infant feeding. Methods: The safety of a new synbiotic infant formula, supplemented with Bifidobacterium lactis and fructo-oligosaccharides, with lactose and a whey/casein 60/40 protein ratio was tested in 280 infants during 3 months. Results: The median age of the infants at inclusion was 0.89 months. Weight evolution was in accordance with the World Health Organization growth charts for exclusive breastfed infants. The evolution of all anthropometric parameters (weight-for-length z score and body mass index-for-age z score) was within the normal range. The incidence of functional constipation (3.2%), daily regurgitation (10.9%), infantile crying and colic (10.5%) were all significantly lower than the reported median prevalence for a similar age according to literature (median value of 7.8% for functional constipation, 26.7% for regurgitation, 17.7% for infantile colic). Conclusion: The new synbiotic infant starter formula was safe, resulted in normal growth and was well tolerated. Functional gastro-intestinal manifestations (functional constipation, regurgitation and colic) were significantly lower than reported in literature. Synbiotics (Bifidobacterium lactis and fructo-oligosaccharides) in cow's milk based infant formula bring the second choice infant feeding, formula, closer to the golden standard, exclusive breastfeeding.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2234-8646 |
ispartof | Pediatric gastroenterology, hepatology & nutrition, 2017, Vol.20 (3), p.167-177 |
issn | 2234-8646 2234-8840 |
language | kor |
recordid | cdi_kisti_ndsl_JAKO201730048508409 |
source | KoreaMed Synapse; PubMed Central Open Access; KoreaMed Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central |
title | Safety of a New Synbiotic Starter Formula |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T00%3A19%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-kisti&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Safety%20of%20a%20New%20Synbiotic%20Starter%20Formula&rft.jtitle=Pediatric%20gastroenterology,%20hepatology%20&%20nutrition&rft.au=Vandenplas,%20Yvan&rft.date=2017&rft.volume=20&rft.issue=3&rft.spage=167&rft.epage=177&rft.pages=167-177&rft.issn=2234-8646&rft.eissn=2234-8840&rft_id=info:doi/&rft_dat=%3Ckisti%3EJAKO201730048508409%3C/kisti%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |